"Vaccinia virus" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The type species of ORTHOPOXVIRUS, related to COWPOX VIRUS, but whose true origin is unknown. It has been used as a live vaccine against SMALLPOX. It is also used as a vector for inserting foreign DNA into animals. Rabbitpox virus is a subspecies of VACCINIA VIRUS.
| Descriptor ID |
D014616
|
| MeSH Number(s) |
B04.280.650.160.650.900
|
| Concept/Terms |
Rabbitpox virus- Rabbitpox virus
- Rabbitpox viruses
- Rabbit Pox Virus
- Rabbit Pox Viruses
Buffalopox virus- Buffalopox virus
- Buffalopox viruses
- virus, Buffalopox
- Buffalo Pox Virus
- Buffalo Pox Viruses
- Virus, Buffalo Pox
- Viruses, Buffalo Pox
|
Below are MeSH descriptors whose meaning is more general than "Vaccinia virus".
Below are MeSH descriptors whose meaning is more specific than "Vaccinia virus".
This graph shows the total number of publications written about "Vaccinia virus" by people in this website by year, and whether "Vaccinia virus" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2001 | 1 | 2 | 3 |
| 2004 | 2 | 1 | 3 |
| 2005 | 3 | 4 | 7 |
| 2006 | 1 | 0 | 1 |
| 2007 | 1 | 0 | 1 |
| 2008 | 2 | 0 | 2 |
| 2009 | 2 | 0 | 2 |
| 2010 | 2 | 0 | 2 |
| 2011 | 3 | 1 | 4 |
| 2012 | 2 | 0 | 2 |
| 2013 | 0 | 1 | 1 |
| 2014 | 0 | 1 | 1 |
| 2015 | 1 | 1 | 2 |
| 2016 | 0 | 1 | 1 |
| 2017 | 9 | 12 | 21 |
| 2018 | 7 | 9 | 16 |
| 2019 | 4 | 4 | 8 |
| 2021 | 1 | 1 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Vaccinia virus" by people in Profiles.
-
Immunogenicity and efficacy of the COVID-19 candidate vector vaccine MVA-SARS-2-S in preclinical vaccination. Proc Natl Acad Sci U S A. 2021 07 13; 118(28).
-
Cellular and Humoral Immune Responses in Mice Immunized with Vaccinia Virus Expressing the SARS-CoV-2 Spike Protein. J Immunol. 2021 06 01; 206(11):2596-2604.
-
One or two injections of MVA-vectored vaccine shields hACE2 transgenic mice from SARS-CoV-2 upper and lower respiratory tract infection. Proc Natl Acad Sci U S A. 2021 03 23; 118(12).
-
A modified vaccinia Ankara vector-based vaccine protects macaques from SARS-CoV-2 infection, immune pathology, and dysfunction in the lungs. Immunity. 2021 03 09; 54(3):542-556.e9.
-
Application of real-time PCR to significantly reduce the time to obtain recombinant MVA virus. J Virol Methods. 2021 03; 289:114056.
-
Development of a multi-antigenic SARS-CoV-2 vaccine candidate using a synthetic poxvirus platform. Nat Commun. 2020 11 30; 11(1):6121.
-
Combating COVID-19: MVA Vector Vaccines Applied to the Respiratory Tract as Promising Approach Toward Protective Immunity in the Lung. Front Immunol. 2020; 11:1959.
-
Two Middle East respiratory syndrome vaccines: first step for other coronavirus vaccines? Lancet Infect Dis. 2020 07; 20(7):760-761.
-
Bacterial Artificial Chromosome-Based Lambda Red Recombination with the I-SceI Homing Endonuclease for Genetic Alteration of MERS-CoV. Methods Mol Biol. 2020; 2099:53-68.
-
Successful establishment of a reverse genetic system for QX-type infectious bronchitis virus and technical improvement of the rescue procedure. Virus Res. 2019 10 15; 272:197726.